Speeding up carcinoma Diagnosis in Egypt: GE Healthcare, Gustave Roussy and therefore the Egypt Ministry of Health Partner to make Rapid carcinoma Diagnosis Clinics

Speeding up carcinoma Diagnosis in Egypt: GE Healthcare, Gustave Roussy and therefore the Egypt Ministry of Health Partner to make Rapid carcinoma Diagnosis Clinics
GE Healthcare, Gustave Roussy and therefore the refore the Egypt Ministry of Health (MOH) signed a preliminary agreement leveraging Gustave Roussy’s One Stop carcinoma diagnostics program to extend the speed and the accuracy of carcinoma diagnosis in Egypt.

Breast cancer is that the commonest cancer in women in Egypt, accounting for 35% of cancers with around 22,000 cases diagnosis in 2020[1]. In July 2019, The President of Egyptian Republic Abdelfattah Al Sissi launched the Women’s Health Initiative, a program to enhance early detection of carcinoma , hypertension, diabetes, osteoporosis, and heart condition . The initiative led by the chief Director Dr. Ahmad Morsi and aimed toward nearly 30 million women above the age of 18, has already been unrolled to 21 million women.

This new collaboration between GE Healthcare and Gustave Roussy, under the patronage of the Egyptian MOH, aims to accelerate this initiative for early detection and treatment planning of carcinoma through the creation of rapid carcinoma diagnosis clinics in Egypt.

Gustave Roussy, a pioneer in “one-stop diagnosis”, has been offering a fanatical reception service since 2004, enabling a diagnosis to be made within each day in most cases of a breast anomaly detected within the city. This multidisciplinary service brings together professionals from different specialities, all experts in carcinoma (radiologists, surgeons, pathologists, oncologists, nurses, technicians, etc.).

This unique pathway demonstrates that coordination between different specialties, processes and innovative technologies are able to do excellent clinical and operational results and reduce the financial cost of carcinoma treatment. Since 2004, quite 21,000 women have participated within the one-stop rapid diagnosis clinic at Gustave Roussy, and quite 80% of them were ready to obtain results and treatment planning if needed an equivalent day.

As a part of the collaboration, Gustave Roussy will train clinical and administrative staff, and support the implementation of ordinary operating procedures and clinical algorithms to assist found out One Stop Clinics within the country. The aim of this collaboration is to enhance the speed and quality of diagnosis and to scale back the prices of care, from consultation and diagnosis to treatment.

“We appreciate GE’s support for the One Stop Clinics, which can contribute to high-efficiency, faster diagnoses – what usually takes weeks can happen within a matter of hours. this may improve treatment response indicators and work toward our goal of saving lives.” Said Dr Khaled Mujahid, spokesperson of the Ministry of Health & Population in Egypt during a statement.

“We are extremely proud that Egypt has chosen to deploy to women the one-stop diagnosis concept invented at Gustave Roussy. Women’s health and therefore the early diagnosis of cancer are causes that mobilize us and that we deploy tons of energy so as to develop new solutions. We are convinced that the hope of curing cancer within the 21st century lies largely within the fields of personalized prevention and rapid diagnosis,” commented Prof. Fabrice Barlesi, CEO of Gustave Roussy.

“GE Healthcare may be a long-term partner in supporting the event of Egypt’s healthcare infrastructure and delivering training for healthcare professionals. Our partnership with the Ministry of Health to hurry up carcinoma diagnostics may be a true milestone within the delivery of world-class healthcare within the country. These new solutions are designed to expand capacity and improve quality and speed for diagnosis and help meet the requirements of community.” said Naël Dabbagh, head for the center East, North East Africa , Turkey and Central Asia at ‎GE Healthcare.

GE Healthcare’s comprehensive diagnostic imaging and monitoring portfolio are often deployed throughout the patient’s cancer or cardiac journey, from initial screening and diagnosis, through therapy guidance facilitating minimally invasive treatment, to monitoring patient progress.

#

About GE Healthcare:

GE Healthcare is that the $18 billion healthcare business of GE (NYSE: GE). As a number one global medical technology and digital solutions innovator, GE Healthcare enables clinicians to form faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the corporate operates at the middle of an ecosystem working toward precision health, digitizing healthcare, helping to drive productivity and improve outcomes for patients, providers, health systems and researchers round the world. Follow us on Facebook, LinkedIn, Twitter and Insights, or visit our website www.gehealthcare.com for more information.

About Gustave Roussy:

Classed because the leading European Cancer Centre and therefore the fifth on the planet stage, Gustave Roussy may be a centre with comprehensive expertise and is devoted entirely to patients suffering with cancer. The Institute may be a founding member of the Paris Saclay Cancer Cluster. it’s a source of diagnostic and therapeutic advances. It caters for nearly 50,000 patients per annum and its approach is one that integrates research, patient care and teaching. it’s specialized within the treatment of rare cancers and sophisticated tumors and it treats all cancers in patients of any age. Its care is personalized and combines the foremost advanced medical methods with an appreciation of the patient’s human requirements. additionally to the standard of treatment offered, the physical, psychological and social aspects of the patient’s life are respected. 3,200 health professionals work on its two campuses: Villejuif and Chevilly-Larue. Gustave Roussy brings together the talents , which are essential for the very best quality research in oncology: 1 / 4 of patients treated are included in clinical trials.